Market Research Blog – Page 14794 – New Product Development

Organoids Market By Application, By End User and By Region, Industry Analysis, Revenue Opportunity, Competitive Analysis

The Global Organoids market study provides critical information related to the global, regional and top players including Organoids market share analysis, winning strategies, recent developments, and financial planning. Besides providing information regarding the key players in the Organoids market, the study also recalibrates, the impact of macroeconomic and microeconomic factors that has the potential to impact the growth of the Organoids market.

Over the past decade, healthcare sector has been expanding remarkably, following the advent of artificial Intelligence and the Internet of Things integrated medical devices. Advancement in technology has created impressive scope within the medical sector for diagnostics and therapeutics.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-8106

Understanding the Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

The FMI’s latest report on the Organoids market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic.

Reasons to Buy the report

We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

Any Queries About Report, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb-8106

Organoids Market: Segmentation

By Region :

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Detailed analysis on the geographical region and country wise insights are offered in the latest Organoids market report with established market players as well as incumbents in the region.

The global Organoids market can be segmented as follows:

By Product Type, Organoids market is segmented as:

Intestinal Organoids
Hepatic Organoids
Pancreatic Organoids
Colorectal Organoids
Neural Organoids
Others

By Application, Organoids market is segmented as:

Bio-banking
Biomedical Research and Drug Discovery
Regenerative Medicine
Cancer Research
Therapeutic Tools
Others

By End User, Organoids market is segmented as:

Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes

Comprehensive analysis of the regional markets offers exclusive insights on the market performance across geographies along with relevant graphs, figures, and list of tables.

Competitive Analysis

By Prominent Market Players:

Cellesce Ltd
DefiniGEN
Qgel
Hubrecht Organoid Technology (HUB)
OcellO B.V.
STEMCELL Technologies Inc.

With an extensive SWOT analysis, the FMI’s study presents the strengths, weaknesses, growth prospects and challenges of each player. The report also includes important data including the sales strategy, pricing strategy, and marketing strategy adopted by these players in the Organoids market

Request For Table of Content @ https://www.futuremarketinsights.com/toc/rep-gb-8106

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the Organoids market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Bioprocess Technology Market Size, Growth Opportunities, Industry Potential, Segmentation Overview, Trends And Forecast Studies 2031

According to a recent study by Future Market Insights (FMI), the global bioprocess technology market was valued at US$ 17.3 Bn in 2020 and is expected to register a CAGR of 15.2% during the forecast period (2021-2031). It is projected to generate a revenue of US$ 81.2 Bn by the end of 2031.

Technology has always been at the heart of biotech. The emergence of advanced computing technology such as machine learning and artificial intelligence has enabled companies to expand the scale of their research and improve efficiency in the manufacturing process—both of which reduce the time it takes for biotech firms to bring new products to market.

Increasing research and development spending on pharmaceutical products has improved the well-being of patients to a significant level. Today vaccines have proven to be one of the most effective ways to prevent children from infectious diseases. This is highly possible due to increased government spending on research & development in the life science stream.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13890

For instance, in May 2020, AbSci Inc. closed USD 15.4 Mn in series D funding to accelerate the growth and scale of disruptive protein printing technology, by announcing an exclusive co-marketing partnership with KBI Biopharma.

There are currently more than 1,500 biomolecules undergoing clinical trials, which target more than 100 hundred types of diseases and success rate for biologics has so far been over twice that of small-molecule products.

Key Takeaways from Bioprocess Technology Market Study

In 2021, the BIOTECH/BIOPHARMACEUTICAL COMPANIES segment is expected to dominate the global bioprocess technology market with a 44.0% market share, whereas, CDMO/contract research organization segment is expected to occupy over 40% of the market share.
By product, the upstream segment dominated the global Bioprocess Technology market with a 64.8% market share.
Europe and East Asia dominated the global bioprocess technology market occupying over 24.3% and 14.7% market share, respectively.

Some of the leading companies of bioprocess technology are focusing on their extensive portfolio of single-use cell culture bioreactors, containers, strong distribution channels, and strategic selling to the leading biopharmaceutical manufacturing entities.

The key market players covered by FMI include Thermo Fisher Scientific Inc, Sartorius, Merck KGa, Danaher Corporation, Applikon Biotechnology B.V., Lonza AG, Bio-Rad Laboratories, Agilent technologies, Solida Biotech GmBH, and Waters Corporation.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13890

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Widefield Imaging Systems Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2031

According to a recent study by Future Market Insights (FMI), the global widefield imaging systems market is expected to register high growth during the forecast period. The market is expected to grow from US$ 556.9 Mn in 2021 to over US$ 1.3 Bn by 2031. It is expected register a CAGR of around 8.6% over the forecast period (2021-2031).

Significant rise in cases of diabetic retinopathy is expected to propel the growth of the global widefield imaging systems market during the forecast period. Widefield retinal imaging includes imaging of peripheral retina that is the main site of various ocular diseases.

Widefield imaging aids in diagnosis of peripheral retina diseases. Occurrence of eye diseases like vision impairment is rising among teenagers. Increasing usage of mobile phones and computers results into digital eye strain, and is mainly responsible for visual impairment among teenagers.

As per the Centers for Disease Control and Prevention, in 2020, approximately 6.8% of children below 18 years have been detected with vision and eye condition in the United States.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1732

Increasing technological awareness and high focus on healthcare innovations are some of the factors encouraging the adoption of these instruments. Additionally, certain companies, as a part of their product strategies, are launching technologically advanced equipment, to consolidate larger market share.

Government funding towards expansion of healthcare infrastructure will support growth in developing countries. Moreover, corporate contracts based on rent-to-own model is a feasible option in emerging economies such as India and Brazil which could create significant opportunities for manufacturers of widefield imaging systems to capitalize on.

Key Takeaways From Widefield Imaging Systems Market Study

Widefield imaging instruments will account for 80% sales in the global market in 2021 of.
Diabetic retinopathy is the most rapidly growing segment by indication, accounting for nearly 1/3rd of the market share.
Standalone type of modality will remain highly preferred, contributing 56.4% towards overall sales in the market in 2021.
Demand in hospitals accounted for 40.2% of widefield imaging systems sales in 2020.
North America will remain the dominant widefield imaging systems market globally, exhibiting a CAGR of nearly 8.6% between 2021 and 2031.

Who Is Winning?

The key market players covered by FMI include Heidelberg Engineering GmbH, Visunex Medical Systems, Inc., Carl Zeiss Meditec AG, Clarity Medical Systems, Inc. Optos plc, and Centervue SpA.

The leading manufacturers of widefield imaging systems are focusing on new product development and launch of advanced versions of existing devices. Their aim is primarily to expand their portfolio to gain competitive edge.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1732

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Positron Emission Tomography Scanners Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2031

The global Positron Emission Tomography (PET) Scanners Market was valued at over US$ 1.2 Bn in 2021 and is expected to exhibit a CAGR of close to 5.1% over the forecast period (2021-2031).

The concept of PET as a nuclear medicine imaging technology was established in early 1970s. Ever since the technology has evolved into routine clinical imaging modality, revolutionizing the process of diseases diagnosis and management into more effective fashion.

PET is a molecular imaging technology that detects the concentration and pharmacokinetics of radiotracer molecules that are labelled with radioisotopes. This helps to diagnose and determine the severity of a various diseases such as neurological disorders, cardiovascular disorders, cancer, gastrointestinal and various others.

Based on the operational and geometrical capabilities of PET scanners, the systems are classified as full ring PET systems and partial ring PET systems. Advancements in technological performance of these systems are always associated with higher cost, limiting its widespread utilization in clinical PET imaging.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1333

Rising prevalence of chronic disorders such as cancer and cardiovascular disorders, coupled with greater awareness towards physical wellbeing and limitations of conventional PET scanner is spurring demand for effective diagnostic techniques, thereby augmenting growth of the market.

PET scanners have continued to improve image quality and performance over the last few years. Technological improvements such as managing dose, reduced imaging time and enhanced lesion detectability have increased PET’s functionality, thus making it easier to interpret and diagnose various life-threatening disorders.

Key Takeaways:

By product, full-ring PET scanner is expected to hold over 86.2% of the total market share by 2031.
Sales in the oncology segment accounted for over 85.2% of market share in 2020, owing to the increasing incidence of chronic diseases and cancer.
Based on detector type, demand in the lutetium oxyorthosilicate (LSO) segment to held over 37.3% of market share in 2020.
Hospitals dominate end user segment with a share of around 34.9% in 2020 due to increasing patient inflow after COVID-19 outbreak.

Who is winning?

Acquisitions, mergers, expansion, and product launches are the key strategies adopted by manufacturers to increase consumer base in different geographies. For instance:

In January 2020, Koninklijke Philips N.V. introduced its advanced solutions called Vereos Digital PET/CT (world’s first and only fully digital, clinically proven, PET/CT solution), an AI-powered solutions for precision diagnosis at IRIA 2020.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1333

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Behavioural Health Market 2022: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2028

According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2021 and Opportunity Assessment 2022–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2022-2028.

North America is expected to hold the highest revenue share in the global behavioural health market over the forecast period. Currently, over 43.8 million adults in the U.S. are suffering from mental illness, which is fuelling demand for behavioral health services. Developing economies are witnessing large demand for home care services, day care services, and internet-counselling services, which is further expected to boost revenue growth of the behavioural health market in emerging markets.

Global Behavioural Health Market: Segmental Analysis & Forecast

The global behavioural health market is segmented based on service type, disorder type, and region. Based on service type the market is segmented into outpatient counselling, intensive case management, home-based treatment services, inpatient hospital treatment, emergency mental health service and others. The inpatient hospital treatment services type segment is expected to represent highest revenue share in the global behavioural health market. Home-based treatment services are expected to gain popularity among people in the coming years and this segment is expected to expand at a CAGR of 4.0% over the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-5375

Based on disorder type the market is segmented into the anxiety disorder, bipolar disorder, depression, eating disorder, post-traumatic stress disorder (PSTD), substance abuse disorder and others. Among all disorder types, the anxiety disorder segment is anticipated to continue to lead the global behavioural health market due to a high patient pool globally and high adoption of behavioural health therapy among patients suffering from anxiety issues. According to the WHO, globally 260 million people are suffering from anxiety disorder.

Increased exposure to drugs and alcohol among young adults and strengthening insurance coverage policies for mental health are identified as key trends among end users in the global behavioural health market. Furthermore, rehabilitation programs for substance abuse disorder patients, outpatient counselling for ADHD affected children, and campaigns to spread awareness regarding mental disorders and drug addiction, etc. are some of the major factors that are driving the growth of the global behavioural health market. Government initiatives to reduce the burden of mental illness and rehabilitation services by non-government organizations (NGO) are further expected to positively impact revenue growth of the global behavioural health market.

Global Behavioural Health Market: Competition Analysis

The global market for behavioural health is fragmented with many local and regional level players operating in the worldwide market. Some of the key players featured in the global behavioural health market report include Acadia Healthcare Co., Inc., Universal Health Services Inc., Magellan Health Inc., National Mentor Holdings Inc., Behavioral Health Services Inc., Behavioral Health Network Inc., North Range Behavioral Health, Strategic Behavioral Health LLC, Seton Healthcare Family (Ascension Health) and Ocean Mental Health Services Inc. etc. among others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5375

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Lab Automation Market size, Insights, Prospects, Growth Trends, Key Trends, Opportunities and Forecast until 2027

According to a recent market report published by Future Market Insights titled, ‘Lab Automation Market – Global Industry Analysis and Opportunity Assessment, 2017–2027’, the global lab automation market is expected to be valued at US$ 1,219.4 Mn in 2017, and is expected to register a CAGR of 9.6% from 2017 to 2027. Lab automation is increasingly being installed by various end users such as pharmaceutical companies, hospitals and diagnostic centers, educational institutions, contract research organizations (CROs), and research institutes. There has been an increase in the usage of lab automation components in hospitals and diagnostic centers, due to an increase in the demand for biochemistry devices.

Dynamics of the Global Lab Automation Market

Increasing incidences of life threatening diseases and injuries have led to increasing diagnostics procedures, worldwide. It is estimated that, the direct and indirect costs of diagnosis will increase over a period of time. The rising research and development activities in the field of molecular and genetics, biochemistry, microbiology, and immunology have also boosted the demand for accurate and cost saving facilities. To develop cost-effective and cost-efficient medical devices and lab automation services, various governments in developed countries are actively funding R&D activities. For instance, the New South Wales (NSW) government in Australia, has provided a medical devices fund of around US$ 8.0 million in 2017-2018 to help encourage and support investments in the development and commercialization of medical devices, related technologies, and services.

Favourable government policies for start-ups enable companies to develop cost-effective healthcare solutions in the lab automation market. Over the last few years, government authorities in Asia Pacific and Middle East and Africa are encouraging start-up companies as well as MNCs to boost industrial growth in the healthcare and medical device industries. Major players in the in-vitro diagnostics market can capitalize on the economies of scale to strengthen their position in the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-394

For instance, India, a developing country in the Asia Pacific region, has announced new policies for attracting MNCs as well as start-up companies across domains, including medical device manufacturing. According to the policies, start-up companies in India are exempt from tax for the first three years after establishment, and patent protection costs are subsidized. Thus, favourable government policies in developing countries are expected to drive overall the lab automation devices and services market.

However, the complex integration of lab tools hinders the demand for lab automation solutions. Lab professionals are focusing on the better utilization of test tools, consolidating various resources and deploying effective lab tools across all platforms. Interconnecting various platforms across the lab is a very critical task, and needs advanced PR-PR open-source high-level robot programming language as a cross-platform laboratory automation system, which may lead to complexity and a variety of test configurations, and restrain the growth of the lab automation market over the forecast period.

Global Lab Automation Market: Segmentation & Analysis

On the basis of component, the global lab automation market is segmented into devices and software. Further, the devices segment has been segmented into six categories – biochemistry devices, molecular devices, hematology devices, immunology devices, microbiology devices, and others. The software segment is bifurcated into two segments scheduling software and momentum integration software.

On the basis of application, the lab automation market is segmented into life sciences research & development, drug-discovery, and diagnostics, in terms of revenue share. The life Sciences R&D segment dominated the global lab automation market in 2017, and is expected to do so throughout the forecast period. The diagnostics application segment is anticipated to expand at the fastest CAGR over the forecast period.

On the basis of end user, the global lab automation market is segmented into pharmaceutical companies, hospitals and diagnostic centers, educational institutions, contract research organizations (CROs), and research institutes. The hospitals and diagnostic centers segment currently accounts for the highest revenue share in the lab automation market, due to the increasing usage of automation devices in hospitals and diagnostic centers in developed countries.

This lab automation market report also covers trends that drive each segment, and offers analysis and insights regarding the potential of the lab automation market in regions such as North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, Middle East & Africa, and Japan. Among these regions, the North American lab automation market is projected to exhibit relatively high growth in the global lab automation market, with a CAGR 10.6% over the forecast period. Revenue from the lab automation market in North America is estimated to account for over 37.1% of the global lab automation market revenue in 2016. Lab automation solution providers can focus on expanding across several countries in North America, such as the U.S. and Canada.

Global Lab Automation Market: Key Players

Some of the key competitors in the lab automation market are Abbott Laboratories, Agilent Technologies, Perkin Elmer, Inc, Thermo Fisher Scientific, Inc, Siemens Healthcare, Danaher Corporation, Becton, Dickinson and Company, and Transcriptic, Inc. These key players are constantly focusing on product innovation and geographical expansions to sustain their market presence and increase revenue generation by developing various types of solutions and delivering outstanding offerings to several end users.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-394

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Continuous Renal Replacement Therapy Market 2017: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2027

Acute kidney injury (AKI) is a common type of kidney disorder with high morbidity and mortality worldwide. Patients from low-resource regions are more prone to acute kidney injuries. The incidence of acute kidney injuries varies greatly in Asia due to significant variation in climate, geographical attributes, ethnic groups and socioeconomic status. The global continuous renal replacement therapy market was valued at US$ US$ 743 Mn in terms of value in 2016, according to a latest research by Future Market Insights (FMI). The report on continuous renal replacement therapy further projects significant growth potential with average year-on-year growth rate of 7.7% through 2027.

Continuous renal replacement therapy is conducted for blood purification in patients suffering from acute kidney injury who unable to withstand rapid fluid and electrolyte exchange of conventional hemodialysis. Continuous renal replacement therapy involves the removal of blood from the arterial lumen catheter through the peristaltic movement and pushing it through a hemofilter before getting pumped into a patient via a venous lumen of catheter. Rising incidence of acute kidney injuries, multiple organ failure and other renal injuries had increased the demand for dialysis sessions.

Numerous advantages of continuous renal replacement therapy over the conventional dialysis procedure is a primary factor driving the adoption of continuous renal replacement therapy. Conventional dialysis systems are operated manually and all associated tasks are solely controlled by the user or caregiver. However, technological advancements in currently available continuous renal replacement systems allows the automatic management of disease parameters. Hence, most of the problems are being directly handled by automated digital machines, which is not possible in case of conventional systems, thus reducing the labour cost.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-1211

To expand their commercial footprint across the globe, several manufacturers of continuous renal replacement therapy are focusing on introducing new technologies and upgrading their existing products along with simultaneous focus on strategic alliances for the sale and promotion of their products. For instance, in 2015, Fresenius Medical Care AG & Co. KGaA launched multi Filtrate PRO, a therapy system for continuous renal replacement therapy for the treatment of acute kidney failure in critically ill patients at intensive care units. Innovations in extracorporeal technologies will play a critical role in the long-term sustainability of continuous renal replacement therapy devices. The advent of continuous renal replacement therapy devices will eventually attract a new patient base. For instance, in September 2017, Baxter International Inc. launched 3-In-1 oXiris Set for sepsis management protocols & continuous renal replacement therapy, which was previously indicated only for continuous renal replacement therapy. The commercialisation of such multimodal devices is expected to enhance the ROI for hospitals. The introduction of novel autonomous CRRT devices will marginally reduce physician intervention and the cost of treatments in intensive care units. The intuitive platform with touch screen and step-by-step automated instructions promotes ease of use during procedures.

Companies are investing in future growth by expanding their healthcare services businesses through acquisitions as well as the purchase of expertise and relevant technologies in the area of research and development. In 2016, Fresenius Medical Care spent US$1.3 Bn on capital expenditures, acquisitions and the purchase of intangible assets minus income from divestments. The majority of capital expenditures were used for equipping existing & new clinics, preserving & expanding production capacity, primarily in North America, Germany, Asia Pacific and France, as well as for dialysis machines made available to customers and for care coordination.

FMI segmented the global continuous renal replacement therapy market into product type, end user & regions. In terms of revenue, the consumables segment is expected to hold a substantial market share over the forecast period. The segment is expected to exhibit a significant CAGR of 8.5% over the forecast period.

FMI’s report covers some of the key companies operating in the continuous renal replacement therapy market, which include Fresenius Medical Care AG & Co. KGaA; Baxter International Inc.; B. Braun Melsungen AG; Medica SpA, Nikkiso Co., Ltd.; Nipro corp.; Toray Medical Co., Ltd.; NxStage Medical, Inc.; Asahi Kasei Corp. and Medtronic plc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1211

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Digital Mobile X-Ray Devices Market Perspective, Comprehensive Analysis, Growth and Forecast 2016-2026

Future Market Insights, in its latest research, delivers key insights on the factors impacting the global digital mobile X-ray device market. According to the report, demand for digital mobile X-ray devices will continue to be fuelled by applications in orthopaedic- and chest-imaging. These two end-use applications accounted for 60% revenue share of the market in 2016.

Key Driving Factors

Increasing emphasis on diagnostic imaging services by various government bodies.
Increasing geriatric population – according to WHO, global geriatric population will reach 2 billion by 2050
Rising incidences of orthopaedic diseases and bone injuries – WHO estimates global prevalence of arthritis to between 0.3% and 1%
Contractual agreements and acquisitions by manufacturers
Increasing adoption of 3D medical imaging equipment, especially in the field of orthopaedics
Increase in the number of free standing imaging centers

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-990

Key Restraints

High cost of clinical trials and stringent regulations have remained longstanding challenges for manufacturers
Lack of inadequate imaging infrastructure in developing countries. High cost associated with initial set up and installation has been identified as a major restraint
Increasing pressure on the healthcare budget in the U.S. and rising awareness among patients about the potential health impact of radiation

By product type, mobile devices will continue to outsell handheld devices. In 2016, of the US$ 7.67 Bn worth of digital X-ray devices sold, 91.5% were mobile devices. However, owing to their small base size, demand for handheld digital mobile X-ray devices will grow at a higher CAGR than mobile devices.

Hospitals and radiology centers will continue to be the leading end-users of digital mobile X-ray devices globally. These two end-users collectively accounted for nearly 70% revenue share of the market in 2016. According to Future Market Insights’ research, these two end-use sectors will continue to account for the bulk of demand for digital mobile X-ray markets during the forecast period.

Competitive Landscape Analysis

Leading companies in the global digital mobile X-ray devices market are General Electric Healthcare Limited, Siemens AG, Esaote SpA, Hitachi Ltd., Koninklijke Philips N.V, Planmed OY, EOS Imaging, and Toshiba Medical Corporation. These leading companies are eyeing the lucrative APEJ market to capitalise on the growing opportunities.

Future Market Insights maintains a positive outlook on the global digital mobile X-ray market, projecting it to grow at 7.1% CAGR through 2026.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-990

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us:

Pharmacovigilance Market By Product Type, By End User and By Region: Industry Analysis, Revenue Opportunity, Competitive Analysis

ESOMAR-certified company Future Market Insights (FMI) has published a report on the global pharmacovigilance market for the forecast period 2021-2031. According to the report, the market is poised to reach new heights, as pharmaceutical companies scramble to introduce new drug candidates for multiple ailments, which will result in an increase in clinical trials.

As per FMI’s analysis, the market is expected to register double-digit growth, experiencing an impressive CAGR throughout the forecast period. Historically, the market posted credible gains, surpassing US$ 6 billion in 2020, expanding at a CAGR of over 14%. Growth prospects were further heightened during the COVID-19 pandemic, as the scramble for new treatment approaches is prompting pharmaceutical companies to initiate clinical trials for the same.

Prominent pharmaceutical companies are forging long-term partnerships and service agreements with contract research organizations and business processing outsourcing units to enhance existing pharmacovigilance operations by virtue of cost reduction from drug delivery to post-marketing approvals. In April 2021, Thermo Fisher Scientific Inc. announced its plans to acquire Pharmaceutical Product Development (PPD) Inc. for a purchase price of US$ 17.4 billion, which will help enhance the latter’s pharmacovigilance portfolio expansion.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1107

Key Takeaways from FMI’s Pharmacovigilance Market Study

By phase of drug development, stage IV clinical trials pharmacovigilance solutions account for over 3 out of 4 applications
Based on method type, targeted spontaneous reporting to make maximum use of pharmacovigilance solutions
By service provider type, contract outsourcing to generate almost two out of five pharmacovigilance solutions uptake
US experiencing robust pharmacovigilance solutions providers presence amid prevalence of good PV practices
Forthcoming clinical trials for numerous drug candidates through 2021 to widen UK’s growth prospects
India to emerge as an emerging pharmacovigilance hub amid growing trends of medical operations outsourcing
China to experience growth on the back of recent amendments to render pharmacovigilance implementation stronger

Key Players:

Accenture Plc.
Bristol-Myers Squibb
Clinquest Group B.V.
Cognizant Technology Solutions
Covance Inc
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc.
ICON Plc
iGATE Corporation
iMED Global Corporation
inVentiv Health Inc.
Novartis AG
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC. (PPD)
PRA Health Sciences Inc.
Quintiles Transnational Holdings Inc.
Sanofi SA
Synowledge LLC
Wipro Ltd.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1107

Competitive Landscape

Prominent pharmacovigilance solutions providers are relying on collaborating with prominent biopharmaceutical and pharmaceutical companies to offer their digital solutions to facilitate effective patient care solutions. Also, offering advanced solutions is another prominent strategy. Some prominent faces include F. Hoffmann- La Roche, GlaxoSmithKline Plc., Covance Inc., ICON Plc. and iGATE Corporation among others.

Covance Inc. is a prominent pharmacovigilance solutions providing, offering end-to-end PV services spanning clinical and post-marketing phases from medical contract centers to ICSRs to medical reviews to electronic regulatory submissions. The system helps track weekly, daily and monthly metrics for quality, productivity and efficiency.

In April 2020, ICON Plc. initiated efforts to enhance pharmacovigilance practices, considering the onset of COVID-19. A webinar conducted on this issue by the company called for key pharmaceutical companies to automate their workflows by installing proactive and dedicated intelligence processes, forging detailed business and continuity plans and a virtually globally distributed footprint.

Pharmacovigilance Market – Key Segments Covered

Phase of Drug Development

Preclinical Studies
Phase I
Phase II
Phase III
Phase IV

Type of Methods

Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining

Service Type Provider

In-house Pharmacovigilance
Contract Outsourcing

Geography

North America (US and Canada)
Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe)
Asia-Pacific (China, India, ASEAN, Japan and Rest of APAC)
Latin America (Brazil, Mexico and Rest of LATAM)
Middle East & Africa (GCC, South Africa and Rest of MEA)

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1107

Vein Finder Market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2028

Advancements in healthcare technology have fuelled a spate of innovations in medical devices, with top-of-the-line product launches presenting enhanced device functionalities. Innovations in vein finder technology are taking the medical devices sector by storm, with advanced vein finders backed by latest technologies acting as a boon for physicians, nurses, and phlebotomists. The last two years have witnessed notable innovations in vein finder technology, the prominent ones being:

The world’s first slide style palm vein authentication technology was introduced in the vein finder market by Fujitsu Laboratories Ltd. in 2017. This compact technology is capable of being integrated into tablets and benchtop mobile devices.
In 2018, Vino Optics launched the Oxy-Iso Paramedic vein glasses, a pair of sunglasses to help physicians and phlebotomists easily locate veins through enhanced image display by filtering ultraviolet rays. This technology is supposedly beneficial for healthcare professionals suffering from colour blindness, as these vein finders help physicians locate veins by enhancing their ability to view reds and greens.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7640

Vein Finder Market Structure Overview: Regional Focus to Bolster Global Market Growth

An overview of the market structure of the global vein finder market reveals a strong regional presence of top market companies as well as local players. Leading companies operating in the global vein finder market are leveraging acquisitions as a primary strategy to facilitate regional market expansion. Future Market Insights analysis also observes a strong focus by vein finder companies on R&D for new product development and expansion of the existing product line in key regional growth markets.

“Implementation of inorganic growth strategies is seen as the way forward to penetrate key growth markets across certain developing regions. Companies in the vein finder market with diversified product offerings are collaborating with local regional players to introduce low-cost vein finder products in order to cement their presence across top regional markets.”

In 2017, the leading three companies in the global vein finder market held a revenue share of about 56% while the remaining players contributed about 44% market share. New product development is a key strategy adopted by players in the global vein finder market to increase their brand value. Rising difficulties associated with peripheral venous access and venepuncture is one of the primary factors boosting growth of the vein finder market and key players are capitalizing on the growth drivers to increase their market share.

Future Market Insights predicts lucrative revenue growth in the various regional markets of Europe and Asia Pacific Excluding Japan. Europe will likely remain the top market for sales of vein finder devices owing to increasing adoption of vein finder across hospitals and clinics to locate veins for drawing blood samples, IV insertions, and other vascular procedures.

Portable Vein Finder to Garner Maximum End User Demand; Infrared Technology to Register Fastest Growth in Revenue, Reveals Future Market Insights

Portable vein finders are likely to be the most preferred product type in the global vein finder market, registering impressive demand as well as sales growth in the coming decade. The convenience and ease of use offered by portable vein finders is the primary factor boosting adoption across hospitals, clinics, and other healthcare institutions. The global vein finder market is fuelled by advanced technology with infrared technology being the most adopted in vein finders. Among the various end users of vein finders, hospitals are likely to exhibit the highest demand in the next 10 years, also contributing to maximum revenues in the global vein finder market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-7640

Why Future Market Insights?

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Contact Us: